News center | United States​

Philips Selects Revolutionary Intravenous Solution as Winner in Innovation Fellows Competition for its Potential To Save Millions of Lives

November 14, 2013

Andover, MA, USA – Philips North America today announced Fosmo Med, developer of the Maji Intravenous (IV) saline bag, as the grand prize winner of the first-ever Philips Innovation Fellows competition, revealing the technology as the next big, meaningful innovation in health and well-being.  The new IV solution technology has the potential to save millions of lives worldwide from dehydration-related diseases, such as cholera.


Maji is a revolutionary field hydration system for IV use that is shipped without water. Once on site, forward osmosis technology converts local water -- even if it's not clean -- to a sterile solution without requiring any electrical power.  An estimated 16 Maji bags can be shipped for the same cost as one traditional IV saline bag, saving up to $500 for every 14 units shipped.*


"We’re very excited to be named the winner of the Philips Innovation Fellows Competition," said  Ben Park, chief executive officer and founder of Fosmo Med. "Maji will enable many more IV bags to be shipped for the same cost, stored safely and transported to remote sites.  The potential life savings could be in the millions annually."


"We are thrilled to name Fosmo Med as the grand prize winner and to support them as they work to take Maji to the market," said Greg Sebasky, chairman of Philips North America. "As a company committed to meaningful innovation, it is gratifying to find a social enterprise that has the potential to revolutionize the medical device industry with a simple, forward-thinking solution."


"Maji shows Fosmo Med’s commitment to providing affordable healthcare and well-being above all else," added Sebasky.


Fosmo Med was selected from among hundreds of entries to the Innovation Fellows Competition. The company secured funding from the public through the crowd funding portion of the competition on Indiegogo, global web-based crowd funding site, and, once named a finalist, the Maji IV saline bag was named the "most meaningful" innovation by Philips employees. In addition  to $60,000 in prize money, Fosmo Med will receive an all-expenses-paid trip to Philips’ USA headquarters to meet with Philips leadership for mentor and whiteboard sessions to support development of the Maji IV.


Other finalists in the competition included Breath AcousticsFilterwatchGame Face Gear and ZG-1: LED. Each of the finalists received a $10,000 cash prize, in addition to the funding raised through Indiegogo.

*Estimated costs for shipment from San Francisco, CA to Conakry, Guinea via FedEx medical device shipping

Image image


Ben Park, chief executive officer and founder of Bay Area-based Fosmo Med, displays the Maji Intravenous (IV) saline bag, the grand prize winning entry of the first-ever Philips Innovation Fellows competition. (AP Photo/Alison Yin).

Image image


Philips North America today announced Fosmo Med, developer of the Maji Intravenous (IV) saline bag, as the grand prize winner of the first-ever Philips Innovation Fellows competition. The social enterprise will receive $60,000 in prize money and mentoring sessions with Philips leadership. (AP Photo/Alison Yin).

For further information, please contact:

Bob Cramblitt

PR Counsel for Fosmo Med
(919) 481-4599 or (919) 434-4813


About Royal Philips:

Royal Philips (NYSE: PHG, AEX: PHIA) is a diversified health and well-being company, focused on improving people’s lives through meaningful innovation in the areas of Healthcare, Consumer Lifestyle and Lighting. Headquartered in the Netherlands, Philips posted 2012 sales of EUR 24.8 billion and employs approximately 114,000 employees with sales and services in more than 100 countries. The company is a leader in cardiac care, acute care and home healthcare, energy efficient lighting solutions and new lighting applications, as well as male shaving and grooming and oral healthcare. News from Philips is located at


You are about to visit a Philips global content page


Our site can best be viewed with the latest version of Microsoft Edge, Google Chrome or Firefox.